Renal Solutions
Renal Solutions Acquired by Fresenius Medical Care
Renal Solutions (RSI) has been acquired by Fresenius Medical Care AG & Co. KGaA (NYSE: FMS, FMS/P). RSI will continue operations as a wholly owned subsidiary of Fresenius Medical Care, the largest integrated global provider of dialysis products and services. Peter DeComo will continue to lead RSI in Warrendale, PA and Oklahoma City, OK. Visit www.renalsolutionsinc.com or www.fmc-ag.com to learn more about the acquisition and the companies.
November 29, 2007 | Permalink
Home Dialysis Clinical Research Study Begins
Renal Solutions has announced that a home use clinical research trial using sorbent technology has begun. The study presents the opportunity for 25 dialysis particpants to evaluate the ability to self-administer extended duration dialysis in the home when using the Allient(R) Sorbent Hemodialysis System. In this study, the use of the Allient System in the home is an investigational use. Patient-focused dialysis centers with certified home programs that are interested in learning more about this home trial should contact Mr. David Vanella, VP of Regulatory Affairs at Renal Solutions, 724-772-6900 ext. 140.
November 8, 2007 | Permalink
Allient System Receives FDA 510(k) Clearance
Renal Solutions has received 510(k) clearance from the US Food and Drug Administration for its Allient(R) Sorbent Hemodialysis System in chronic and acute hemodialysis applications. The new system features improvements in ease of manufacturing, service and user-friendliness. In preparation for the Allient System commercialization, Renal is also launching its SMARRT(TM) platform and campaign, which will introduce the benefits of advanced sorbent therapy to the renal community. For more information, read the press release here, and visit www.renalsolutionsinc.com.
October 23, 2007 | Permalink
Renal Solutions Agrees to Make Wearable Artificial Kidney
Renal Solutions has reached a technology development agreement with Innovative BioTherapies to make a wearable artificial kidney. The process will begin with Renal Solutions' marketing of a refrigerator-size unit in the 4th quarter of this year, which the companies then will work to miniaturize. Innovative BioTherapies president, Dr. H. David Humes, expects animal testing by the end of the year, and human testing to begin in five years. Read more about upcoming plans and developments in the Pittsburgh Business Times, or visit www.renalsolutionsinc.com.
August 23, 2007 | Permalink
Entrepreneurial Funding Looking Up in Pittsburgh
In a recent article in the e-zine, Pop City, Pittsburgh venture capitalists spoke out about the future of entrepreneuship and venture funding in Pittsburgh. The article states that new companies received $230 million in investment dollars -- the largest growth in VC investment of any area in the country. Don Jones believes that today's angels are helping to develop successful companies, who, in turn, help develop other successes. "What we need is to reach a critical mass for the domino effect to be self-perpetuating. There needs to be families of successful companies that spin off each other." For the full article, check out popcitymedia.com.
July 17, 2007 | Permalink
Renal Solutions Forms Medical Advisory Board
Renal Solutions has formed a Medical Advisory Board comprised of a team of key nephrology thought leaders with experience in clinical, academic and private practice settings, both nationally and internationally. The newly-formed Medical Advisory Board will provide strategic advice in the areas of medical issues, clinical use studies, product development, and market introduction. Members include: Derrick L. Latos, MD, MACP (Chairman), John Agar, MBBS, FRCP(Lond), FRACP, Stephen R. Ash, MD, FACP and Robert S. Lockridge, Jr., MD.
July 20, 2006 | Permalink
Donald W. Joseph Joins Renal Board
Donald W. Joseph has been appointed to the Board of Directors for Renal Solutions. Renal is the exclusive provider of advanced sorbent hemodialysis products and services for treatment of patients with renal failure. Mr. Joseph is currently President & CEO of Sorbent Therapeutics, Inc., a company focused on solutions for patients with fluid balance deficiencies. Previously, Mr. Joseph served as Group Vice-President, Corporate Officer and CEO & President of Baxter's Global Renal Business. Mr. Joseph successfully led the strategic development, implementation and growth of Baxter, increasing revenuew from $20 million to $2 billion.
June 29, 2006 | Permalink
Renal Solutions Announces FDA 510(k) Clearance
The U.S. Food & Drug Administration has granted 501(k) clearance of the Allient Sorbent Hemodialysis System, including the SORB series and the HISORB series cartridges from Renal Solutions. The FDA clearance of the Allient System addresses recent system enhancements which enable improved reliability and performance. The Allient System opens new treatment options to dialysis professionals and patients by virtue of its ability to provide short, standard or extended duration hemodialysis therapy using just 1 1/2 gallons of ordinary dirinking water. This translates into increased transportability, flexibility and ease of system use.
June 8, 2006 | Permalink
Pete DeComo a Finalist for E&Y Entrepreneur of the Year
Pete DeComo, CEO of Renal Solutions, has been named a finalist in the 2006 Ernst & Young Entrepreneur of the Year awards program in the Upstate New York and Western Pennsylvania region. Award winners will be announced at a special 20th anniversary gala event on June 16th at the Hilton Hotel in Pittsburgh. Awards are given to entrepreneurs who have demonstrated excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Congratulations, Pete!
May 25, 2006 | Permalink
Aethon, BodyMedia, Renal Solutions Amoung Tech50
The Pittsburgh Technology Council's Technology 50 celebrates the southwestern Pennsylvania region's 50 leading technology-oriented companies in five categories: Advanced Manufacturing, Information Technology, Life Sciences, Rising Star and Service Provider. Aethon was a finalist in the Information Technology category; BodyMedia and Renal Solutions in the Life Sciences category. Congratulations to all of the firms named. For more information, visit the Tech50 homepage.
December 6, 2005 | Permalink
Renal Solutions and T-Med Bring Sorbent Hemodialysis to the UK and Ireland
Renal Solutions has signed an exclusive distribution agreement with T-Med, a leading European distributor of medical, diagnostic and dialysis solutions, to have T-Med distribute the Allient® Sorbent Hemodialysis System in the United Kingdom and Ireland. The Allient technology will assist the UK National Health Services achieve its goal of increasing the percentage of patients who utilize home hemodialysis to 10-15% from its present level of under 2%. For more information, visit the Renal Solutions website.
November 3, 2005 | Permalink
Sorbent Dialysis Subject of Article in Dialysis & Transplantation
Susan Hansen, Business Development Manager at Renal Solutions, published an article in the September 2005 issue of Dialysis & Transplantation. The article gives an in-depth look at the history of Sorbent dialysis and where the technology and industry are heading. The Journal is published monthly and reaches a worldwide circulation of 24,000+.
September 8, 2005 | Permalink
Pittsburgh Technology Council Announces Tech50 Category Leaders
The Pittsburgh Technology Council's annual Technology 50 honors those technology companies that demonstrated the strongest growth and advancement in product or sales success, financial strength, corporate citizenship, job growth and retention and innovative product or technology. We're pleased to say that this year Aethon (Information Technology), BodyMedia (Life Sciences), and Renal Solutions (Life Sciences) have all made the list. The annual gala to announce the category winners will be held on October 20.
August 15, 2005 | Permalink
Renal Solutions Ready for Commercial Sales
With preliminary FDA approval in hand, the Pittsburgh Business Times reports that Renal Solutions is set to receive the first of its portable kidney dialysis system this week to begin testing to ensure they were built to the company's specifications. Insitutional sales to nursing homes and hospitals will begin over the next several months. Sales to the home user market will wait until further trials are run and final FDA approval is granted. The Company expects final approval for sale to home users early in 2006.
August 9, 2005 | Permalink
Renal Solutions Receives FDA Clearance
Renal Solutions has received clearance from the US Food & Drug Administration (FDA) to begin commercialization of the Allient® Sorbent Hemodialysis System in chronic and acute hemodialysis applications. The company also received approval of an Investigational Device Exemption (IDE) for the initiation of a home hemodialysis clinical trial. Pete DeComo, CEO, expressed his pleasure with the "broad label indication for use in chronic and acute hemodialysis as prescribed by a physician." For more information, read the full release.
June 23, 2005 | Permalink
Renal Solutions to Present at CIBC Conference
Renal Solutions will present at the CIBC World Markets Fifteenth Annual Healthcare Conference on Tuesday, November 9 at the Plaza Hotel in New York City. Chairman and CEO, Peter M. DeComo will present an overview of the Company and its progress in the commercialization of its revolutionary technology, the Allient® Sorbent Hemodialysis System. The presentation will be webcast live over the Internet. To listen to the presentation, go to Renal's website and follow the webcast link on the home page.
November 5, 2004 | Permalink
Pete DeComo Finalist for Entrepreneur of the Year
Pete DeComo, of portfolio company Renal Solutions, has been named a finalist for the Ernst & Young Entrepreneur of the Year 2004 Awards in southwestern PA. The press release is available here.
June 29, 2004 | Permalink
Renal Solutions Receives FDA Clearance
Renal Solutions received 510(k) clearance from the FDA to market their new and enhanced version of the SORB and HISORB sorbent regenertive hemodialysis cartridges. Read the full release here.
October 1, 2003 | Permalink
Gerald E. McGinnis Named to Renal Solutions Board
Renal Solutions announced in a news release the appointment of Gerald E. McGinnis to the company's Board of Directors. Mr. McGinnis is Chairman and founder of Respironics and completes the Board as its 7th member and as an outside Director.
August 21, 2003 | Permalink
Renal Solutions Completes Financing Round
Renal Solutions announced today the completion of a Series A financing totaling $18 million.
July 30, 2003 | Permalink
